Table 6 Cellular contributors to brain colonization.
Cell | Cell markers | Secreted molecules | Cell-to-cell interaction | Roles in TME |
|---|---|---|---|---|
Astrocyte | GFAP+, S100β+ | PA | Tumor cell apoptosis Suppression of cancer progression and metastasis | |
GFAP+, CD274+ | ET-1 TNF, IL-6 CCL2 | Cx43 gap junction (astrocyte–cancer cell) | Tumor growth Chemotaxis Immune suppression | |
TAM-BMDM | Iba1+, CD49d+, Tmem119−, P2ry12−, Siglech−, Sall1− | Midkine IL-10, TGFβ | PD-1 (CTL)–PD-L1 (TAM) TIM-3 (TAM)–Galectin-9 (cancer cell) SIRPα (TAM)–CD47 (cancer cell) | Immune suppression Tumor survival TME differentiation |
TAM-MG | Iba1+, CD49d−, Tmem119+, P2ry12+, Siglech+, Sall1+ | IL-6, IL-8, IGF, CCL20 | PD-1 (CTL)–PD-L1 (TAM) TIM-3 (TAM)–Galectin-9 (cancer cell) SIRPα (TAM)–CD47 (cancer cell) | Invasion and migration Tumor survival Immune suppression |
T cell | CD3+, CD4+, CD8+ | IFNγ | PD-1 (T cell)–PD-L1 (cancer cell) PD-1 (T cell)–PD-L1 (TAM) LAG-3 (T cell)–MHC-II (cancer cell) TCR (T cell)–MHC (cancer cell) | Immune response |
Treg | CD4+, CD25+, FOXP3+ | IL-10, TGFβ | PD-1 (Treg)–PD-L1 (cancer cell) LAG-3 (Treg)–MHC-II (cancer cell) CTLA-4 (Treg)–CD80/86 (cancer cell) | Immune suppression TME differentiation |